14 November 2021 : Clinical Research
Clinical Features and Temporal Lung Radiographic Changes in 25 Patients Recovering from COVID-19 Pneumonia: A Retrospective Case-Control Study
Chao Hu1ABCDEG, Jian Ping Zeng2ACDFG, Ke Peng3ABCDF, Hong Xia4BCEF, Huan Ming Zhang5BCDEF, Zhi Zhong5BCDE, Ming Yan Jiang1ABDFG*DOI: 10.12659/MSM.933381
Med Sci Monit 2021; 27:e933381
Table 3 Comparison of treatment and prognosis between patients with moderate and severe COVID-19 pneumonia.
| Moderate (n=17) | Severe (n=8) | P | |
|---|---|---|---|
| Antiviral therapy from onset, days | 6.39±3.84 | 6.0±3.42 | 0.245 |
| Use of corticosteroids | 1 (5.56%) | 8 (100%) | <0.001 |
| Nasal cannula (<4 L/min) | 17 (100%) | 8 (100%) | -- |
| Nasal cannula (>4 L/min) | 0 (0%) | 8 (100%) | -- |
| Non-invasive ventilation or high-flow nasal cannula | 0 (0%) | 3 (37.5%) | -- |
| Hospital stays, days | 12.5 (9.75–18.5) | 18.5 (15.5–22.5) | 0.062 |
| Hospitalization cost, RMB | 7663.27 (5967.08–10 390.50) | 42 401.85 (31 788.01–58 536.64) | <0.001 |